Diabetic kidney disease: Act now or pay later

American Journal of Nephrology

Volumn 31, Issue 2, 2010, Pages

  Atkins, Robert C ^a   Zimmet, Paul ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; LIPID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALBUMINURIA; AWARENESS; BLOOD PRESSURE REGULATION; BUDGET; CHINA; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE COURSE; ECONOMIC DEVELOPMENT; GLOMERULUS FILTRATION RATE; GOVERNMENT; HEALTH CARE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEART DEATH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPAIRED GLUCOSE TOLERANCE; INDIA; INDONESIA; INFECTION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; KOREA; LAW; LIFESTYLE MODIFICATION; MALARIA; MEXICO; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; PHYSICIAN; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PRODUCTIVITY; PUBLIC HEALTH; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCREENING; SOCIOECONOMICS; THAILAND; TUBERCULOSIS; UNITED NATIONS;

DIABETIC NEPHROPATHIES; DISEASE OUTBREAKS; HEALTH PROMOTION; HUMANS; NEPHROLOGY; PREVENTIVE MEDICINE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 77649322945     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000280547     Document Type: Conference Paper

References (28)

1. International Diabetes Federation and International Society of Nephrology, Diabetes and kidney disease: time to act. 2003:Brussels.
2. Zimmet P, Alberti K, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
3. King H, Aubert R, Herman W: Global burden of diabetes, 1995-2025:prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
4. Yoon K, et al: Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368: 1681-1688.
5. Sicree R, Shaw J, Zimmet P: Diabetes and impaired glucose tolerance, in Diabetes Atlas, 3rd edition, D. Gan, Editor. 2006, International Diabetes Federation: Brussels. p. 15-109.
6. Reutens AT, Prentice L, Atkins R: The Epidemiology of Diabetic Kidney Disease., in The Epidemiology of Diabetes Mellitus, 2nd Edition, J. Ekoé, et al., Editors. 2008, John Wiley & Sons Ltd: Chichester. p. 499-518.
7. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. International comparisons, in 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2007, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. : Bethesda. p. 239-254.
8. Appendix II, in ANZDATA Registry Report 2008, McDonald S., Excell L., and Livingston B: Editors. 2008, Australia and New Zealand Dialysis and Transplant Registry: Adelaide. p. 1-97.
9. Yamagata K, et al: Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol 2008; 12: 1-8.
10. Lysaght M: Maintenance dialysis population dynamics: Current trends and long term implications. J Am Soc Nephrol 2002: 13:S37-S40.
11. Adler A, et al: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225-232.
12. Retnakaran R, et al: Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006; 55: 1832-1839.
13. Parving H, et al: Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69: 2057-2063.
14. Ninomiya T, et al: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009; 20: 1813-1821.
15. Dunstan D, et al: The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
16. White S, et al: Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008; 188: 204-208.
17. Whaley-Connell A, et al: Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009; 53 (suppl 4):S11-S21.
18. Thomas M, Viberti G, Groop P: Screening for chronic kidney disease in patients with diabetes: are we missing the point? Nat Clin Pract Nephrol 2008; 4: 2-3.
19. Holman R, et al: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
20. Bilous R: Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabet Med 2008: 25(suppl 2):25-29.
21. Gaede P, et al: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
22. Patel A, et al: Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829-840.
23. ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
24. Zoungas S, et al: The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care 2009. [Epub ahead of print].
25. Ruggenenti P, et al: Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351: 1941-1951.
26. Parving H, et al: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878. (Pubitemid 34940826)
27. Lewis E, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Eng J Med 2001; 345: 851-860.
28. Burney B, Kalaitzidis R, Bakris G: Novel therapies of diabetic nephropathy. Curr Opin Nephrol Hypertens 2009; 18: 107-111.